Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Trials in Immune-Oncology
By Christine Filippis / September 6, 2019
The expansion of immunotherapies is a key trend to watch in cancer research 28 August, Sophie Laurenson, PhD https://www.clinicallabmanager.com Immunotherapy...
Read More
The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy
By Christine Filippis / September 5, 2019
CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive...
Read More
MEETING ON THE MESA: Cartherics heads to California
By Christine Filippis / September 3, 2019
By Leigh Dayton, 2 September 2019 Cartherics has been invited to present at the prestigious Cell & Gene Meeting on...
Read More
